JPH0513132B2 - - Google Patents

Info

Publication number
JPH0513132B2
JPH0513132B2 JP60260868A JP26086885A JPH0513132B2 JP H0513132 B2 JPH0513132 B2 JP H0513132B2 JP 60260868 A JP60260868 A JP 60260868A JP 26086885 A JP26086885 A JP 26086885A JP H0513132 B2 JPH0513132 B2 JP H0513132B2
Authority
JP
Japan
Prior art keywords
water
drug
release
elution
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60260868A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62120315A (ja
Inventor
Tooru Chiba
Fujio Sekikawa
Hiroyasu Kokubo
Kyoshi Araume
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shin Etsu Chemical Co Ltd
Original Assignee
Shin Etsu Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Etsu Chemical Co Ltd filed Critical Shin Etsu Chemical Co Ltd
Priority to JP26086885A priority Critical patent/JPS62120315A/ja
Publication of JPS62120315A publication Critical patent/JPS62120315A/ja
Publication of JPH0513132B2 publication Critical patent/JPH0513132B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
JP26086885A 1985-11-20 1985-11-20 経口投与型徐放性錠剤の製造方法 Granted JPS62120315A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP26086885A JPS62120315A (ja) 1985-11-20 1985-11-20 経口投与型徐放性錠剤の製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26086885A JPS62120315A (ja) 1985-11-20 1985-11-20 経口投与型徐放性錠剤の製造方法

Publications (2)

Publication Number Publication Date
JPS62120315A JPS62120315A (ja) 1987-06-01
JPH0513132B2 true JPH0513132B2 (en:Method) 1993-02-19

Family

ID=17353866

Family Applications (1)

Application Number Title Priority Date Filing Date
JP26086885A Granted JPS62120315A (ja) 1985-11-20 1985-11-20 経口投与型徐放性錠剤の製造方法

Country Status (1)

Country Link
JP (1) JPS62120315A (en:Method)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223619A (en) * 1987-02-27 1990-10-26 Lilly Co Eli Sustained release tablet containing cefaclor, a hydrophilic polymer and an acrylic polymer
DE3810343A1 (de) * 1988-03-26 1989-10-05 Basf Ag Verfahren zur herstellung von festen pharmazeutischen retardformen
US5174998A (en) * 1988-11-30 1992-12-29 Nisshin Flour Milling Co., Ltd. Sustained release compositions using as matrix hemicellulose extracted from wheat bran
WO1994003159A1 (en) * 1992-07-31 1994-02-17 Daratech Pty. Ltd. Controlled release implants
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
PT996429E (pt) * 1997-10-27 2003-06-30 Merck Patent Gmbh Solucoes e dispersoes no estado solido de farmacosfracamente soluveis em agua
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
WO2004016249A1 (en) * 2002-08-14 2004-02-26 Ranbaxy Laboratories Limited Extended release matrix tablets
JP4837895B2 (ja) * 2003-03-17 2011-12-14 武田薬品工業株式会社 放出制御組成物
EP2063872B2 (en) 2006-08-30 2019-12-04 Jagotec AG Controlled release oral dosage formulations comprising a core and one or more barrier layers
EP2090298A4 (en) * 2006-11-13 2014-02-26 Kyorin Seiyaku Kk METHOD FOR PRODUCING A TABLET WITH DELAYED RELEASE
JP5699339B2 (ja) 2010-02-12 2015-04-08 日産化学工業株式会社 徐放性製剤
US20120039999A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120251588A1 (en) * 2011-03-30 2012-10-04 Miyuki Fukasawa Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation
WO2019098300A1 (ja) 2017-11-16 2019-05-23 日本新薬株式会社 放出制御製剤
US12427145B2 (en) 2019-02-03 2025-09-30 Innovate Therapeutics Llc Controlled release pharmaceutical composition of Selexipag or it's active metabolite

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS55118414A (en) * 1979-03-05 1980-09-11 Teijin Ltd Prolonged release drug and its preparation
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration

Also Published As

Publication number Publication date
JPS62120315A (ja) 1987-06-01

Similar Documents

Publication Publication Date Title
JP2519296B2 (ja) イブプロフェン除放性錠剤及びその製造方法
JP3140465B2 (ja) ハイドロゲル徐放性製剤
EP0157695B1 (en) Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
CA1331344C (en) Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
US5451409A (en) Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US4842866A (en) Slow release solid preparation
CA2354057C (en) Sustained release tablet containing hydrocolloid and cellulose ether
JP5400377B2 (ja) 圧縮性に乏しい治療用化合物を有する組成物の製造法
EP1035838B1 (en) Pharmaceutical suspension tablet compositions
US20110071137A1 (en) Process for preparing sustained release tablets
LV10182B (en) Memantine-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof
JPH0513132B2 (en:Method)
JPH01250314A (ja) 徐放性製剤
JP5420590B2 (ja) ｐＨ非依存延長放出性医薬組成物
JP2007532620A (ja) 両親媒性デンプンを含む医薬組成物
JPWO1994006414A1 (ja) ハイドロゲル徐放性製剤
CA2212309C (en) Extended-release solid oral dosage forms of drugs having low solubility in water
CN111840239B (zh) 一种普瑞巴林缓释制剂
US20060088594A1 (en) Highly compressible controlled delivery compositions of metformin
JP5208729B2 (ja) 徐放性錠剤の製造方法
JP2686215B2 (ja) 徐放性錠剤
JPH0757726B2 (ja) 高分子量ヒドロキシプロピルメチルセルロースを基剤にした徐放性錠剤
JP3598049B2 (ja) ハイドロゲル徐放性製剤
JPH02121919A (ja) 柔軟性を有する錠剤
CN112168796A (zh) 双相缓释系统控制释放的药物缓释制剂及其制备方法

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term